Another new MIDAS publication this week @arc_nwc `The prevalence of comorbidity in rheumatoid arthritis: a systematic review and meta-analysis' doi.org/10.12968/bjcn.…
6/6 Reviewing research such as this and transferring knowledge to patients is part of the role as an ARCNWC public adviser co-lead. More info on the work of our public advisers can be found here: bit.ly/3uWboS2#publicadvisers#ARCNWC
4/6 A RaCES project by ARCNWC partners at UCLan and Lancashire and South Cumbria NHS Foundation Trust has critically appraised a review of factors associated with the risk of relapse for RRMS: bit.ly/3NRBw9p
3/6 Did you know that Relapse Remitting Multiple Sclerosis (RRMS) is the most common type, affecting approximately 85% of MS patients. Is RRMS multifactorial? Which factors influence the risk of relapse? #MS#research#LivingwithMS
2/6 How does research help those with chronic illness, such as the millions of persons with Multiple Sclerosis (MS), the most common neurological disability. Recent research offers further knowledge #MSResearch#LivingwithMS
1/6 The following thread has been produced by our Co-Theme leads for MIDAS (Public Advisers: Gerry Allen and Patricia Jamal) who have reviewed the findings of a RaCES project: Risk factors for relapse in Relapse Remitting Multiple Sclerosis.
.@arc_nwc's RaCES programme converts systematic reviews into evidence summaries to inform practice 💡
RaCES have had a range of #ARCimpacts from informing decisions about safety culture tools to guiding development of training resources.
➡️ Learn more: arc-nwc.nihr.ac.uk/midas/overview…